title: Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report.
abstract: Classic Kaposi's sarcoma (KS) is a disease with low mortality but high morbidity. The optimum treatment of KS depends upon several factors, including location of lesions, disease progression, severity of symptoms and patient preference. We report the long-term response to the use of intralesional doxorubicin to successfully treat a large cutaneous lesion of KS on a patient refractory to traditional treatments.
authors.affiliation: Department of Dermatology, Princess Alexandra Hospital NHS Trust, Harlow, UK.
authors.forename: Yasir Azim
authors.initials: YA
authors.lastname: Mirza
authors.affiliation: Department of Dermatology, Princess Alexandra Hospital NHS Trust, Harlow, UK.
authors.forename: Davide
authors.initials: D
authors.lastname: Altamura
authors.affiliation: Department of Dermatology, Princess Alexandra Hospital NHS Trust, Harlow, UK.
authors.forename: Torkan
authors.initials: T
authors.lastname: Hirbod
authors.affiliation: Department of Dermatology, Princess Alexandra Hospital NHS Trust, Harlow, UK.
authors.forename: Roberto
authors.initials: R
authors.lastname: Verdolini
keywords: Classic Kaposi's sarcoma; Intralesional doxorubicin; Kaposi's sarcoma; Treatment
references.citation: Br J Dermatol. 2010 Apr;162(4):854-9
references.pmid: 19995366
references.citation: J Am Acad Dermatol. 2013 Feb;68(2):313-31
references.pmid: 22695100
references.citation: N Engl J Med. 1995 May 4;332(18):1181-5
references.pmid: 7700310
references.citation: Br J Dermatol. 1993 Nov;129(5):590-3
references.pmid: 8251357